In endometrial tumors that deeply invaded the myometrium, a 3-fold increase in the KRAS protein level was observed, along with a slightly higher pATR expression (2.1-fold), while the number of pCHEK1 positive cells did not depend on the depth of tumor invasion into the myometrium. The gene discussed is KRAS; the disease is endometrium neoplasm.